![Abraham Bout](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Abraham Bout
Amministratore Delegato presso Bioceros Holding BV
Profilo
Abraham Bout is currently the Chairman & Chief Executive Officer at Bioceros Holding BV.
He is also a Member of the Supervisory Board at Polpharma Biologics Utrecht BV.
Previously, he served as the Director at Adenovirus Research Group and as the Principal at Crucell NV.
He was also a Member at Cellutions, Inc. and the Vice President-Protein Production at Janssen Vaccines & Prevention BV.
Additionally, he held the position of Chief Technology Officer at ProFibrix BV.
Dr. Bout obtained his undergraduate and doctorate degrees from the University of Amsterdam.
Posizioni attive di Abraham Bout
Società | Posizione | Inizio |
---|---|---|
Polpharma Biologics Utrecht BV
![]() Polpharma Biologics Utrecht BV Miscellaneous Commercial ServicesCommercial Services Polpharma Biologics Utrecht BV operates as a biopharmaceutical research and development company. It specializes in the development of monoclonal antibodies generation, cell line, upstream process, downstream process, analytical, and bioassay development services. The company is headquartered in Utrecht, the Netherlands. | Direttore/Membro del Consiglio | - |
Bioceros Holding BV
![]() Bioceros Holding BV Miscellaneous Commercial ServicesCommercial Services Bioceros Holding BV develops monoclonal antibodies and generating GMP-ready cell lines. engages in building therapeutic monoclonal antibodies, including targets in oncology and auto-immune diseases. It generates various cell lines that produce proteins ranging from blood proteins and monoclonal antibodies to fusion proteins. The company is headquartered in Utrecht, the Netherlands. | Amministratore Delegato | - |
Precedenti posizioni note di Abraham Bout
Società | Posizione | Fine |
---|---|---|
Janssen Vaccines & Prevention BV
![]() Janssen Vaccines & Prevention BV Pharmaceuticals: MajorHealth Technology Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands. | Corporate Officer/Principal | - |
Crucell NV
![]() Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Corporate Officer/Principal | 01/01/2007 |
Cellutions, Inc.
![]() Cellutions, Inc. Medical SpecialtiesHealth Technology Cellutions, Inc. develops proprietary medical devices. It provides proprietary technology and novel device-based treatment for the cosmetic appearance of cellulite. The company was founded in 2004 and is headquartered in Duluth, GA | Corporate Officer/Principal | - |
ProFibrix BV
![]() ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands. | Direttore Tecnico/Scientifico/R&S | - |
Adenovirus Research Group | Direttore/Membro del Consiglio | - |
Formazione di Abraham Bout
University of Amsterdam | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 7 |
---|---|
Polpharma Biologics Utrecht BV
![]() Polpharma Biologics Utrecht BV Miscellaneous Commercial ServicesCommercial Services Polpharma Biologics Utrecht BV operates as a biopharmaceutical research and development company. It specializes in the development of monoclonal antibodies generation, cell line, upstream process, downstream process, analytical, and bioassay development services. The company is headquartered in Utrecht, the Netherlands. | Commercial Services |
Janssen Vaccines & Prevention BV
![]() Janssen Vaccines & Prevention BV Pharmaceuticals: MajorHealth Technology Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands. | Health Technology |
Crucell NV
![]() Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Health Technology |
Adenovirus Research Group | |
ProFibrix BV
![]() ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands. | Health Technology |
Cellutions, Inc.
![]() Cellutions, Inc. Medical SpecialtiesHealth Technology Cellutions, Inc. develops proprietary medical devices. It provides proprietary technology and novel device-based treatment for the cosmetic appearance of cellulite. The company was founded in 2004 and is headquartered in Duluth, GA | Health Technology |
Bioceros Holding BV
![]() Bioceros Holding BV Miscellaneous Commercial ServicesCommercial Services Bioceros Holding BV develops monoclonal antibodies and generating GMP-ready cell lines. engages in building therapeutic monoclonal antibodies, including targets in oncology and auto-immune diseases. It generates various cell lines that produce proteins ranging from blood proteins and monoclonal antibodies to fusion proteins. The company is headquartered in Utrecht, the Netherlands. | Commercial Services |
- Borsa valori
- Insiders
- Abraham Bout